Epidermolysis Bullosa, also known as "butterfly disease," is a rare genetic condition. This congenital disease lets the skin be as fragile as those of butterfly wings. Affected patients can develop painful blisters and sores easily, proving life very difficult to live for all their daily activities. Though its prevalence is extremely rare, estimated to occur in 1 of each 50,000, the impact of this disease on children born with severe forms of the disease is immense.
Although the problems associated with butterfly disease are tremendous, there is a promise of improvement with advancements in gene therapy and other treatments. Research and innovations such as topical gene therapy are bringing new hope for the management of symptoms and possibly curative solutions in the future.
This article delves into the complexities of butterfly disease, including its causes, symptoms, and current developments in treatments, along with essential care tips for managing the condition.
Butterfly disease is a collection of very rare genetic conditions that cause severe skin fragility. Even the slightest pressure or friction from clothing, touch, or minor injuries can cause the skin to tear or blister. The blisters can occur anywhere on the body, including internally, such as in the mouth, gastrointestinal tract, and eyes.
Children with EB are sometimes referred to as "butterfly children" because their skin is fragile, just like the wings of a butterfly. In less severe cases, blisters may primarily occur on the hands, knees, or elbows. In the most severe cases, blistering can be all over the body, leading to scarring, deformities, and even life-threatening complications.
EB, butterfly disease, originates from mutations that damage the structure of the skin. These mutations result in broken bonds between layers of the skin and cause separation at stress points. There are 30 different subtypes, but they all fit into one of four larger categories based on where the lesions affect the skin.
The most common subtype, epidermolysis bullosa simplex (EBS), accounts for about 70% of cases. It is typically inherited in an autosomal dominant pattern, meaning a single defective gene copy from one parent can cause the condition. Other, less common forms may require two defective gene copies—one from each parent—making them autosomal recessive.
The symptoms of butterfly disease vary according to subtype and severity. Generally, all kinds of EB share the hallmark feature of fragile skin that blisters and tears easily.
There are severe complications with the more severe forms of EB where blisters form in areas of the eyes, airway, and gastrointestinal tract. Such may lead to conditions such as:
Infections: Open sores are easily susceptible to bacterial infections that may eventually result in deadly sepsis.
Malnutrition and dehydration: Inability to eat due to blisters in the mouth and esophagus.
Risk of cancer: Squamous cell carcinoma is a skin cancer with an increased risk of development.
Life expectancy varies according to the severity. The milder forms of the disease tend to improve with age, while the severe types usually result in early death. Most patients die before reaching the age of 30 years.
Also Read: Smurf Syndrome: Rare Condition That Turns Your Skin Blue-Gray Permanently
Currently, there is no cure for butterfly disease; however, the advancements recently done can offer a much better management system along with improved quality of life.
Gene Therapy
In 2023, the FDA approved a revolutionary gene therapy gel called Vyjuvek. This gel targets dystrophic epidermolysis bullosa, a severe subtype caused by mutations in the gene responsible for producing a crucial type of collagen in the skin. Vyjuvek helps heal wounds and prevent further damage by delivering functional copies of the gene directly to affected cells.
Other Treatments Involve
For severe patients, complications may necessitate surgery, including correction of esophageal strictures or deformity due to scar tissue.
Caring for butterfly disease needs a lot of attention to prevent complications and ease pain.
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa. New England Journal of Medicine. 2022
(Credit-Canva)
With a global estimate of 20 million cases in 2022, cancer is the leading cause of death worldwide. Cancer diagnoses can turn people’s lives upside down, as the diagnosis is followed up by treatments such as chemotherapy, immunotherapy, or even surgeries. The best way to deal with cancer is catching it early, however the chances of catching it early are very low. Many people only visit their doctors when they see concerning symptoms, but that could also mean that the cancer has progressed much further, reducing the chances of survival.
A new small pilot study suggests that a type of blood test could potentially find signs of cancer up to three years before it would typically be diagnosed. These tests, called multicancer early detection (MCED) tests, look for tiny bits of genetic material that tumors release into the bloodstream.
This special MCED test works by looking for what's called "tumor DNA" in your blood. Tumors, which are growths of cancer cells, shed little pieces of their genetic material into your bloodstream. The test is designed to pick up on these tiny clues. In the study, it actually found this cancer DNA in some people's blood up to three and a half years before they were officially diagnosed with cancer.
Researchers from Johns Hopkins, said that finding cancer this early could lead to much better results for patients. It's like getting a head start on fighting the disease. They also mentioned that we'd need to figure out the best way to follow up with someone if this test came back positive so early.
For this initial study, the researchers looked at blood samples that were already collected for a big heart disease study. They used the MCED test on two groups: 26 people who were diagnosed with cancer within six months of giving their blood, and 26 similar people who didn't get cancer.
The results were quite telling: eight of the 52 blood samples came back positive on the MCED test. And sure enough, all eight of those people were diagnosed with cancer within just four months of their blood sample being taken. The types of cancers found included colon, pancreatic, rectal, lung, breast, and liver cancer. Sadly, five of these eight patients later passed away from their cancers. This shows how serious these diseases are, even when found relatively early.
To push the boundaries even further, the researchers looked at older blood samples from six of those eight patients. These samples were taken a remarkable three to three and a half years before their cancer diagnosis.
They found tumor DNA in four of those much older samples! This strongly suggests that these cancers could have been spotted years earlier, which could have given doctors a significant head start on treatment. Researchers explained that this study really shows how promising MCED tests are for finding cancers very early. They believe it sets a new standard for how sensitive these tests need to be to truly be successful.
While these findings are very exciting, it's important to remember this was a small pilot study. We need much bigger studies to confirm these results. However, the initial findings strongly suggest that this type of blood test could be a game-changer, helping us catch cancers when they are much smaller and easier to treat, increasing the chances of survival.
The researchers also pointed out that their main goal was to show how early cancer DNA can be detected in the blood, not just to prove a new test works. They also noted that to find cancers three or more years before a diagnosis, these blood tests will need to be 50 times more sensitive than the ones currently used to detect cancers within six months.
Credits: Canva
Auto-Brewery Syndrome, also known as gut fermentation syndrome, is a rare medical condition where the digestive system produces alcohol internally. This happens when certain microorganisms—mostly yeasts like Candida or some bacteria—ferment carbohydrates in the gut, creating ethanol. The ethanol then enters the bloodstream, causing symptoms such as dizziness, disorientation, fatigue, and even slurred speech, mimicking alcohol intoxication.
ABS typically occurs when the natural balance of the gut microbiome is disrupted. This disruption can follow antibiotic use, gastrointestinal infections, or diets high in refined carbohydrates. In some cases, people with diabetes or existing gut disorders are more prone to developing the condition.
When the gut environment changes, fermentative microbes may flourish. These microbes thrive on simple carbohydrates and sugars, converting them into alcohol during digestion. While most people efficiently digest these foods without any issue, those with ABS experience a build-up of ethanol, leading to unwanted and surprising symptoms.
Bread—especially white or refined varieties—is rich in simple carbohydrates. For most people, eating bread in moderation doesn’t cause harm. In fact, whole grain bread can be beneficial due to its fibre content, which supports healthy digestion and feeds good gut bacteria.
However, when eaten in excess, particularly in its refined form, bread can contribute to an overgrowth of fermentative microbes in susceptible individuals. This can lead to symptoms like bloating, gas, discomfort, and, in rare cases like ABS, internal alcohol production.
To support gut health, many wellness experts recommend incorporating psyllium husk, or Isabgol, into your routine. Psyllium is a soluble fibre that absorbs water and forms a gel-like substance in the gut. This helps regulate bowel movements, slows down carbohydrate absorption, and may prevent the rapid fermentation of food in the intestines.
By stabilizing digestion and reducing the speed at which carbs are broken down, psyllium can help minimise gas, bloating, and the risk of ethanol build-up—making it a helpful tool for those concerned about gut health.
Managing ABS or preventing gut issues doesn't require drastic changes. Here are a few everyday habits that support better digestion:
Auto-Brewery Syndrome is an unusual and extreme case, but it highlights a powerful truth: the food we eat shapes our internal health in surprising ways. Paying attention to our gut and making mindful dietary choices can go a long way in supporting not just digestion, but overall well-being.
(Credit-Canva)
You may know about people who avoid certain foods like peanuts, berries or eggs because they are allergic to it, but what does that mean? Food allergies can happen to anyone. It is a condition where your body’s natural defenses overreact to exposure to a particular substance. The American College of Allergy, Asthma & Immunology explains that our body’s immune system basically mistakes food or a particular particle as an invader or a threat to your body.
This then causes your immune system to release ‘defense’ chemicals that can cause reactions like nausea, swellings, dizziness or worse, anaphylaxis. Anaphylaxis is a whole-body reaction that can impair your breathing and cause a dramatic drop in blood pressure. Life-threatening reactions like such are the reason why many parents are apprehensive about introducing certain foods to their children. However, could that be the reason why children are developing more allergies?
A new study published in the European Journal of Clinical Nutrition found that some parents are waiting much longer—a year or even more. Many parents, understandably worried, might actually be preventing their children from avoiding food allergies. Experts now say that introducing tiny amounts of common allergy-causing foods like peanuts and eggs to babies as young as 4 to 6 months old can help them build a strong defense. This delay could mean their children don't get the chance to become tolerant to these foods, increasing their risk of developing allergies.
The study looked at what parents are feeding their babies and found some interesting, and perhaps concerning, trends:
Nuts: About 35% of babies hadn't eaten nuts by their first birthday.
Eggs: Similarly, around 21% of parents hadn't given their one-year-olds any egg.
Sesame: And for sesame, 16% of babies hadn't tried it by age one.
These numbers come from a survey of parents in the UK, who are part of a study tracking their children's health over time.
For many years, parents were told to avoid giving allergenic foods to babies and even during pregnancy. The idea was to prevent allergies. However, we now know that this advice might have actually made allergies more common, especially in children.
Researchers explain that studies as such are very important. Parents must update themselves regarding new food allergy guidelines. This understanding is important as if parents keep waiting to introduce these foods, it will continue to fuel the "allergy epidemic" we're seeing.
The researchers talked to nearly 400 parents involved in a project tracking children's health from birth. They found that most children did start eating common allergenic foods like eggs and nuts when they were between 6 and 9 months old. However, many parents still chose to wait longer for certain foods:
Sesame: About 26% of parents waited until their child was older than 9 months.
Fish: 25% delayed introducing fish.
Nuts: 21% waited longer for nuts.
Eggs: 11% held off on eggs.
The researchers concluded that even parents whose families had a history of allergies weren't following the updated advice. Many babies weren't exposed to nuts and eggs by their first birthday, which is a key time for building tolerance.
These findings suggest that the new guidelines about food allergies aren't reaching new parents clearly enough. Research consistently shows that introducing allergenic foods early, especially nuts and eggs, lowers the risk of developing allergies. In fact, for babies at high risk of allergies, experts even suggest introducing peanut-containing foods as early as 4 to 6 months of age. It's crucial for this message to get out so more children can benefit from these updated recommendations.
© 2024 Bennett, Coleman & Company Limited